Analyst Ratings For NUVA – NuVasive (NASDAQ:NUVA)
Today, Goldman Sachs initiated coverage on NUVA – NuVasive (NASDAQ:NUVA) with a Neutral with a price target of $47.00.
Some recent analyst ratings include
- 4/4/2018-Goldman Sachs initiated coverage with a Neutral rating.
- 2/27/2018-Robert W. Baird Reiterated Rating of Hold.
- 2/27/2018-Barclays Reiterated Rating of Overweight .
- 2/27/2018-Morgan Stanley Reiterated Rating of Equal Weight .
- On 3/6/2018 Gregory T Lucier, CEO, bought 6,000 with an average share price of $50.30 per share and the total transaction amounting to $301,800.00.
- On 3/1/2018 Gregory T Lucier, CEO, bought 6,000 with an average share price of $48.57 per share and the total transaction amounting to $291,420.00.
- On 8/29/2017 Gregory T Lucier, CEO, bought 2,000 with an average share price of $61.52 per share and the total transaction amounting to $123,040.00.
- On 8/18/2017 Lesley H. Howe, Director, sold 3,970 with an average share price of $64.64 per share and the total transaction amounting to $256,620.80.
- On 8/17/2017 Gregory T Lucier, CEO, bought 5,000 with an average share price of $66.22 per share and the total transaction amounting to $331,100.00.
- On 8/1/2017 Peter Michael Leddy, EVP, bought 7,850 with an average share price of $63.88 per share and the total transaction amounting to $501,458.00.
- On 3/8/2017 Jason Hannon, Insider, sold 24,840 with an average share price of $74.22 per share and the total transaction amounting to $1,843,624.80.
Recent Trading Activity for NUVA – NuVasive (NASDAQ:NUVA)
Shares of NUVA – NuVasive closed the previous trading session at 53.29 down -0.35 0.65% with 588109 shares trading hands.